81276 Kras gene additional variants
Also known as: Extended KRAS analysis, KRAS full gene mutation testing
KRAS proto-oncogene GTPase (KRAS) gene analysis for additional variants beyond exon 2, including exons 3 and 4 mutations.
In Plain Language
Additional KRAS mutation detection; Comprehensive cancer mutation test
Clinical Context
Detects less common KRAS mutations in exons 3 and 4 that may have therapeutic implications not detected by exon 2 alone analysis.
RVU Information
CPT 81276 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81276?
CPT 81276 (Kras gene additional variants) is a Pathology & Lab code. KRAS proto-oncogene GTPase (KRAS) gene analysis for additional variants beyond exon 2, including exons 3 and 4 mutations.
Who uses CPT code 81276?
CPT 81276 is used by Pathology, Oncology, Gastroenterology. Detects less common KRAS mutations in exons 3 and 4 that may have therapeutic implications not detected by exon 2 alone analysis.
When is CPT 81276 used?
Detects less common KRAS mutations in exons 3 and 4 that may have therapeutic implications not detected by exon 2 alone analysis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.